Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105).
作者信息
Maruyama Dai, Iida Shinsuke, Machida Ryunosuke, Kusumoto Shigeru, Fukuhara Noriko, Yamauchi Nobuhiko, Miyazaki Kana, Yoshimitsu Makoto, Kuroda Junya, Tsukamoto Norifumi, Tsujimura Hideki, Usuki Kensuke, Yamauchi Takahiro, Utsumi Takahiko, Mizuno Ishikazu, Takamatsu Yasushi, Nagata Yasuyuki, Ota Shuichi, Ohtsuka Eiichi, Hanamura Ichiro, Suzuki Yasuhiro, Yoshida Shinichiro, Yamasaki Satoshi, Suehiro Youko, Kamiyama Yutaro, Fukuhara Suguru, Tsukasaki Kunihiro, Nagai Hirokazu
机构信息
Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan.
出版信息
Cancer Sci. 2022 Sep;113(9):3267-3270. doi: 10.1111/cas.15484. Epub 2022 Jul 31.
Zotero 插件